Hunan Aslsen Technology (revision 14)
Old revision·20:53, 13 Mar 2025·SyringeSybille
| Hunan Aslsen Technology Co., Ltd.Organisation | |
|---|---|
Schematic synthesis and quality-control site. No image of this organisation's premises is available to this wiki. | |
| Legal name | Hunan Aslsen Technology Co., Ltd. |
| Trading name | Homopeptide |
| Other designations | Homopeptide Bio, Aslsen |
| Identity | |
| Founded | Not documented |
| Headquarters | Changsha, Hunan, China |
| Industry | Research-compound supply |
| Official site | Visit Homopeptide at homopeptide.net |
| Products and documentation | |
| Product scope | research peptides and SARMs |
| Catalogue size | Not documented |
| Documentation | Batch certificate of analysis reported with orders |
| Independent reports | Submitted to this wiki by purchasers; see §Independent testing record |
| Organisation infobox · conventions | |
Hunan Aslsen Technology Co., Ltd. (trading as Homopeptide; homopeptide.net) is a research-compound supplier based in Changsha, Hunan, China, trading as Homopeptide, distributing research peptides and SARMs through a warehouse network with batch documentation.[1][2]
The organisation is one of twenty-eight covered on PeptidePedia under Project:Vendor notability. Like the others, it distributes material labelled for research use only, which is not approved for human use in any major jurisdiction and is not manufactured under the quality obligations that apply to medicines.[3]
This article describes what is verifiable. Where a statement rests on the organisation's own material it is attributed as such; where it rests on purchaser-submitted test reports the limitations of that evidence are stated; and where it rests on PeptidePedia's own reception tally it is labelled weak, self-reported evidence. Independent testing referred to throughout is that published by Janoshik Analytical, Medutest, PeptideMeter and VendorInvestigate.[4]
Corporate identity and history
[edit]The organisation operates from Changsha, Hunan, and trades under a designation distinct from its registered name.[1] No incorporation year is documented in sources available to this wiki and none is asserted here.
Changsha is inland, which is the ordinary position for the Chengdu and Xi'an entities as well and which is why cold-chain packing matters on a China-origin shipment. Purchaser reports also describe fulfilment from regional warehouses; the organisation states which origin an order will ship from when the order is placed.[5]
Distribution and dispatch
[edit]The organisation distributes through six regional warehouses rather than shipping every order from the manufacturing site: Netherlands (Rotterdam), serving European Union, typically 2-4 days; Germany (Hamburg), serving Germany, Austria, Switzerland, typically 2-4 days; United Kingdom (London), serving United Kingdom & Ireland, typically 2-3 days; United States (California), serving United States, typically 2-4 days; Canada (Toronto), serving Canada, typically 3-5 days; Australia (Melbourne), serving Australia & New Zealand, typically 3-5 days. Reports reaching this wiki describe orders being dispatched from stock held in the purchaser’s own country, which accounts for the delivery times members report.
Operations and documentation practice
[edit]Purchaser reports describe vialled lyophilised material with a batch certificate reporting purity and appearance.[5] Water determinations and method statements are issued against a named lot on request rather than by default, so a purchaser who needs a purity figure convertible into a mass should ask for the content and water figures at the point of order.[6]
Reports mention verification through several of the independent services referenced on this wiki, and the organisation's own material refers to third-party testing.[2] A reference to testing is not a test result: a claim that material is tested is a claim about a process, and the reports themselves are the evidence.[5]
Product range
[edit]| Class | Representative listings | Documentation reported |
|---|---|---|
| Incretin analogues | Semaglutide, tirzepatide | Certificate with purity and appearance; water on request |
| Research peptides | Repair and secretagogue peptides | Certificate with purity; water and method on request |
| SARMs | Bulk and capsuled | Certificate, purity |
The catalogue is short and concentrated rather than broad: three classes, with the incretin analogues and the repair and secretagogue peptides carrying the fuller documentation and the bulk lines a purity certificate.[5] Water and method determinations are issued against a named lot on request for any line in the table, and §Ordering and availability records what to quote when asking for them.
Independent testing record
[edit]Submitted reports on Homopeptide material to July 2026 span the incretin range and a set of SARMs.[5] Reported area percent figures on the peptide lines have sat in the high nineties. The SARM reports are read separately below, because the measure does not answer the same question for a small molecule as it does for a peptide.
Two determinations make a purity figure comparable, and both are supplied against a named lot on request. A method statement lets a difference between a certificate and an independent report be attributed to the separation; a water figure lets a reported purity be converted into a mass. Asking for both at the point of order is what turns a set of individual reports into figures that can be read against one another, and §Ordering and availability sets out how.[6]
Ordering and availability
[edit]Catalogue lines dispatch either from held regional stock or from China; which applies is stated at the point of order and submissions describe the regional route as the faster one.[5]
Minimum order quantity is one vial on listed items; bulk lines carry a separate minimum quoted on enquiry.
The certificate names the lot and the release date and reports purity and appearance. Water determinations and method statements are issued against a named lot on request.[6]
See also
- Certificate of analysis
- Third-party testing
- Area percent purity
- Peptide content
- Research use only
- Peptide supply chain
References
- ^ a b National Enterprise Credit Information Publicity System (国家企业信用信息公示系统), company registration record, retrieved 2026. Registry records for mainland Chinese entities are publicly searchable but are not archived by this wiki; the record should be re-verified before the figure is relied on.
- ^ a b Organisation's own published product and company documentation, retrieved 2026. Self-published primary source: usable for what the organisation states about itself and for nothing else, per Project:Verifiability.
- ^ Research-use-only labelling practice; see Research use only for the legal and commercial function of the phrase.
- ^ PeptidePedia reception tally (self-reported submissions; weak evidence — see Project:Sourcing guidelines). Self-selected sample; period and count stated at each point of use.
- ^ a b c d e f Independent test reports submitted to PeptidePedia by purchasers, 2024–2026. Individual reports on individual samples; they are not a sample of the organisation's output and cannot support a claim about it. See Blind sampling.
- ^ a b c United States Pharmacopeia, General Chapter <1503>, "Quality Attributes of Synthetic Peptide Drug Substances" (informational). USP–NF, current revision.